ArticleDrug delivery2021

Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy.

Fengkun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.